Likewise, IL‐17/Th17 deficiency105 or treatment with IL‐17R antagonist/IL‐17 neutralizing antibody106 have been shown to ameliorate arthritis development in mice coincided with reduced joint damage.107. This evidence concerns the gene IL17A and arthritic joint disease.